Observational Study of Kibow Biotics in Chronic Kidney Failure Patients on Dialysis

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

October 31, 2012

Conditions
Chronic Kidney Disease
Interventions
DIETARY_SUPPLEMENT

Kibow Biotics

6 month, double-blind, cross-over, wash-out, placebo controlled study in an outpatient setting. Each patient takes two capsules, three times a day (180 CFU/day).

Trial Locations (1)

11226

Parkside Dialysis Clinic at Downstate Medical Center, Brooklyn

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

State University of New York - Downstate Medical Center

OTHER

lead

Kibow Pharma

INDUSTRY